Macrophages surrounded and adhered to macroconidia and large hyphal elements. More macrophages (65 to 68%) from BCG-treated mice contained fungi at 24 h than did macrophages from normal or vaccinated mice. Although there was no increase in the number of fungi in macrophages from vaccinated mice, only the macrophages from BCG-treated mice contained fewer fungi after 48 h of infection with the mycelial phase of H. capsulatum. Fungal growth was not inhibited in any of the macrophage cultures when infected with the yeast phase. The macrophages infected with yeast cells were destroyed after 48 to 72 h in the culture. Only BCG-treated macrophages survived infection with the mycelial phase, whereas macrophages from normal and vaccinated mice were destroyed by the infection.
Histoplasmosis results from the inhalation of airborne mycelial-phase particles of Histoplasma capsulatum (6) . The mycelial phase consists of hyphae, macroconidia, and microconidia. Microconidia have been suggested as the most important infectious particle because of their size (3 to 5 pm), which enables them to reach alveolar spaces (7) . Infection is common in endemic areas such as Kentucky, and host responses vary from inapparent infection to disseminated disease. Many studies on histoplasmosis have focused on the tissue or yeast phase of the fungus, disregarding the mycelial phase as the infective agent. In vitro studies with peritoneal macrophages and yeast-phase cells have provided useful information on the fate of yeast cells in normal and immune macrophages (10) . Yeast-phase cells are able to grow inside nonimmune macrophages with a generation time of about 11 h (9). It is thought that macrophages require T-cell interaction for fungicidal action against the yeast phase of H. capsulatum (11 This study was done to determine the relationship between the time of conversion of the mycelial phase to the yeast phase and phagocytosis of the fungi by macrophages. The rates-of phagocytosis of the different phases of the fungi by alveolar and peritoneal macrophages from normal, vaccinated, and Mycobacterium bovis BCG-treated mice were compared, and the fate of the intracellular fungi was studied.
(The findings from this study were presented in part at the 81st Annual Meeting of the Amer- (Beilco Glass, Inc., Vineland, N.J.), at 250C for 4 to 6 weeks. The purity and morphology were checked by microscopic observation (X400) of lactophenol cotton blue-stained wet mounts. The mycelial growth on the agar surface was removed by adding 20 ml of sterile phosphatebuffered saline, pH 6.8, and 1 g of glass beads (diameter, 1 mm) and shaking for 1 to 5 min with a Vortex mixer. The suspension of mycelial particles was again shaken for 1 to 5 min with a Vortex mixer to separate tbe macroconidia, microconidia, and hyphal fragments. Mycelial-phase components in suspension were centrifuged at 1,200 x g for 10 min, washed twice with sterile phosphate-buffered saline, and finally suspended to the required concentration in RPMI 1640 medium containing 20% fetal calf serum (FCS), penicillin (100 U/ml), and streptomycin (40 ug/ml) (GIBCO Laboratories, Grand Island, N.Y.). Viability of the particles was determined by plating serial 10-fold dilutions in duplicate onto plates of beef extract agar with 1% peptone. Particles were counted in a Neubauer counting chamber. A control culture of the mycelial-phase components in RPMI 1640 medium-FCS was incubated at 370C in 5% C02, and conversion to the yeast phase was observed.
The yeast phase was grown on brain heart infusion (Difco Laboratories) agar slants that contained 5% sheep blood at 370C in a moist atmosphere at 5% C02 and air. Purity and morphology were checked daily by microscopic observation (x400) of lactophenol cotton blue-stained wet mounts. Broth subcultures were made by inoculation of 104 yeast cells from a 4-to 5-day-old brain heart infusion agar slant to 500 ml of brain heart infusion broth. The broth cultures were incubated at 370C on a gyratory shaker at 200 rpm (New Brunswick Scientific Co., New Brunswick, N.J.). Yeast cells were harvested after 72 h by centrifugation at 1,200 x g for 10 min, washed twice with sterile phosphate-buffered saline, and resuspended to the required concentration in RPMI 1640 medium-20% FCS. Viability was determined by dilution plating on brain heart infusion agar, and cell counts were done with a Neubauer counting chamber.
Animals. Male Swiss albino mice (SWR/J) weighing 25 g were housed in groups of 10 (8) . Briefly, the mice were sacrificed by an overdose of pentabarbitone sodium administered intraperitoneally. After the mice were secured to a dissection board, the skin and overlying tissues were aseptically removed to expose the cartilaginous rings of the trachea. A small incision was made between the rings, and a 3/4-in. (ca. 2.18-cm) cannula (diameter, 0.7 mm) attached to a 26-gauge, 1/2-in. (ca. 1.27-cm) needle was inserted into the trachea and secured tightly with a sterile cotton thread. One milliliter of lavage fluid consisting of RPMI 1640 medium-10% FCS with 12 mM lignocaine hydrochloride (Sigma Chemical Co., St. Louis, Mo.) prewarmed to 37°C was instilled gently into the lungs by a syringe affixed to the needle hub. After 3 min and a gentle massage to the chest, 0.6 to 0.7 ml of the lavage fluid was carefully removed. We performed a second and third lavage by adding 0.7 ml of the lavage medium, waiting 1 min, and gently massaging the chest area before removing the lavage fluid. A total volume of 2.0 to 2.5 ml of pooled, bronchopulmonary lavage fluid was collected from each mouse. The fluids were centrifuged at 1,200 x g for 20 min, washed with RPMI 1640 medium to remove the lignocaine, centrifuged again, and suspended again in RPMI 1640 medium-20% FCS with antibiotics to an appropriate concentration. Cell counts were done with a Neubauer counting chamber. Viability was determined by the exclusion of 0.1% trypan blue dye. A differential count of 200 cells stained with Wright stain was done.
Cell suspensions of 105 viable macrophages in 0.75 ml of RPMI 1640-20% FCS with antibiotics were added to each well of a tissue culture, four-chamber slide (Lab-Tek Products, Naperville, Ill.). Cells were allowed to settle and adhere for 2 h at 370C in a moist chamber of 5% C02 and air. After this incubation, the medium was removed from each well and pooled, and the nonadherent cells were counted. Sample wells with adherent cells were stained for acid naphthylesterase activity by the method of Weir (15) .
We obtained macrophages from mouse peritoneal cavities by injecting 5 ml of lavage fluid intraperitoneally, massaging gently for 15 min, and then removing 4 ml of the fluid. The cells were washed, resuspended in RPMI 1640 medium-20% FCS, cultured, and characterized as described for the alveolar macrophages.
Parasitization of the macrophages in vitro. Alveolar and peritoneal macrophages cultured from the normal, vaccinated, and BCG-treated mice were infected in the following manner. The cell culture medium was removed and replaced with fresh medium containing either mycelial-phase particles or yeast cells in a ratio of 5:1 to the macrophages. The infected macrophage cultures were incubated as previously described. Triplicate wells representing each test and noninfected control from all of the animal groups were observed at 2, 4, 6, 12, 24, 48, and 72 h postinfection. The medium from each well was carefully removed by suction pipetting. Wells were washed three times with 0.5 ml of sterile phosphate-buffered saline to remove remaining fungal particles that were not attached to or engulfed by macrophages. The slides were observed by phase microscopy to determine whether the fungi were intracellular. The slides were fixed in absolute methanol for 1 min and stained with periodic acidSchiff stain using 0.2% light green counterstain (5) . After the slides were air dried, a cover slip was placed over them with permount and they were observed microscopically at magnifications of x100 and x400. The macrophages and the engulfed fungal particles were counted, and the type of fungal particle was determined, i.e., budding yeast bation at 37°C, and predominantly budding yeast forms were seen after 72 h in both control and macrophage cell cultures. Table 2 shows the percentage of macrophages containing one or more fungal particles at 24 h. Only 33 to 40% ± 6% of the alveolar and peritoneal macrophages from normal and vaccinated mice contained fungal particles at 24 h, whereas 65 to 68% ± 5% of the macrophages from BCG-treated mice contained fungi. Although the cells were observed at early time intervals, no differences in the percentage of macrophages containing fungi were noted until 24 h after infection.
At 24 h after infection with the mycelial phase of H. capsulatum, the macrophages from BCGtreated mice were apparently able to destroy the fungi as the number of fungal particles per macrophage decreased until at 72 h only 10% of the macrophages contained recognizable fungal particles. The macrophages from normal mice had no apparent effect on the growth and viability of the fungi. Macrophages from vaccinated mice did not destroy the fungi, but may have slowed fungal growth. When extracellular fungi were removed after 24 h but the parasitized normal macrophages were allowed to incubate with fresh medium, the number of fungi per macrophage increased from an average 2.7 to 5.6, and the percentage of macrophages that had phagocytized fungi increased from an average of 35 to 51%. These data suggest that the fungi grew within the macrophages or were released and rephagocytized or grew within the macrophages and were released and rephagocytized. The microconidia and short hyphal fragments were phagocytized by macrophages at rates comparable to yeast-phase cells. The macrophages were not able to phagocytize larger structures, i.e., macroconidia (18 to 25 ym) and long hyphal elements. These structures were surrounded by the macrophages, but it is not clear whether the cells affected the fungi. Due to competition for nutrients or toxic fungal byproducts, the macrophages died in cultures containing the large particles if the culture medium was not changed at 12-to 18-h intervals.
Although macrophages from BCG-treated mice were able to destroy fungi when infected with mycelial-phase particles, they were not able to destroy yeast-phase cells (Table 3 ). More BCG-treated macrophages remained viable and attached during the mycelial infection than did macrophages from normal and vaccinated mice. After 72 h, only 10 to 15% of the macrophages from normal and vaccinated mice remained attached, whereas 70 to 80% of the macrophages from BCG-treated mice remained viable and attached to the slides. The macrophages infected with yeast-phase cells were destroyed after 42 to grow within and destroy macrophages greater than that of small mycelial-phase particles. This study indicates that the yeast-phase cells resist the fungicidal activity of BCG-treated macrophages, but mycelial-phase particles do not. Mycelial-phase particles were taken up at a slightly slower rate in normal macrophages than in macrophages from vaccinated or BCG-treated mice. However, only the macrophages from BCGtreated mice were able to destroy the fungi. There was no change in the number of fungi per macrophage when cells from vaccinated mice were observed at 24 and 48 h. The fungi remained viable, whereas the macrophages lost viability after 48 h and became detached from the slides.
Peritoneal and alveolar macrophages from all groups of mice were observed to surround and attach to macroconidia and long hyphal fragments that were too large to be phagocytized. Investigations are in progress to determine whether this phenomenon results from specific chemotactic factors. There was no apparent effect by macrophages on the structure or viability of these fungal particles. The fungi remained viable after 72 h. The attached macrophages contained smaller particles, but it is unknown whether these particles were from conversion of the larger attached macroconidia and hyphae or obtained from the surrounding medium.
Howard (11) reported that growth of the yeast phase of H. capsulatum cells is inhibited within peritoneal macrophages from immunized (sublethally infected) animals, but the fungi are not killed. This study confirms this finding in both peritoneal and alveolar macrophages from mice immunized with heat-killed yeast cells. Further studies must be done to explain the fungicidal activity of macrophages from BCG-treated mice. BCG-activated macrophages have increased immunoglobin G and C3b receptors (13) , lysozyme content, and morphological changes (12) . BCG provides resistance in animals to several heterologous pathogens and to tuberculous infections (14) . This resistance is due in part to increased intracellular killing of organisms (2) .
Studies are being continued to determine whether opsonic factors, such as immunoglobulins and alveolar lining fluid, have any effects on phagocytosis and fungicidal activities of alveolar macrophages. Additionally, the in vivo and in vitro interactions of alveolar macrophages and H. capsulatum are being compared by using cells from mice that have been infected by the aerosol route with the mycelial phase of the fungus.
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